Universal prophylaxis, targeted prophylaxis, and/or preemptive therapy for opportunistic infections at the time of initiation of combination antiretroviral therapy for patients with advanced HIV Infection.
Dinubile
Mark J
MJ
D017088:AIDS-Related Opportunistic Infections / Q000175:diagnosis / Q000188:drug therapy / Q000517:prevention & control*; D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects* / Q000379:methods; D018791:CD4 Lymphocyte Count; D018890:Chemoprevention; D003906:Developing Countries; D015658:HIV Infections / Q000175:diagnosis / Q000188:drug therapy*; D015276:Health Care Rationing; D006801:Humans; D054019:Immune Reconstitution Inflammatory Syndrome / Q000453:epidemiology*; D012307:Risk Factors